A FLORIDA SEA TOW CAPTAIN SAVED A MAN FROM A BURNING SHIP ONLY TO BE SHOVED OVERBOARD AND HAVE HIS BOAT STOLEN.(PHOTO)

Image
 No good deed goes unpunished.  A Florida sea tow captain saved a man from a burning ship only to be shoved overboard and have his boat stolen. This shocking incident occurred near Marco Island on March 6th. On that date, a call went out regarding a burning boat. The captain of a sea tow boat heard the distress call and rushed to provide aid. He was able to quickly locate the burning boat and  discovered 40-year-old, Ryan Deiter, and his dog onboard the burning ship. Wasting no time, the captain of the sea tow boat was able to maneuver alongside the distressed boat and begin efforts to extricate Deiter and his dog from the doomed vessel.  Eventually, the sea tow captain was able to pull both Deiter and his dog onboard the tow boat. However, once Deiter was pulled to safety, he repaid a stranger's kindness with treachery.  Deiter shoved the captain from his own boat and fled the scene in the stolen boat, leaving the man who had just risked his own vessel and life...

GSK SEEKS APPROVAL FOR WORLD'S FIRST MALARIA VACCINE.

A jogger runs past a signage for pharmaceutical giant GlaxoSmithKline (GSK) in London April 22, 2014. REUTERS/Luke MacGregor            According to sources,the company Glaxo Smith Kline {GSK} said today thursday that it is applying for regulatory approval for the world's first vaccine against malaria,designed for children in Africa.The British drugmaker said the shot called RTS,S,is intended exclusively for use outside the European union but will be evaluated by the European medicines Agency {EMA} in collaboration with World Health Organisation {WHO}.Malaria,a mosquito borne parastic disease,kills more than 600,000 people a year,mainly babies in the poorest parts of sub Saharan Africa.Experts have long hoped that scientists would be able to develop an effective vaccine against the disease,and scientists at GSK have been working on this one for 30 years.The WHO,has previously indicated it may recommend use of RTS,S from as early as 2015 if EMA drugs regulators back its license application.GSK has been developing RTS,S with the non profit PATH malaria vaccine initiative {MVI},with grant funding from the Bill and Melinda Gates foundation to MVI.The vaccine also contains an adjuvant,or booster,made by U.S biotech company Agenus,which received an undisclosed milestone payment for the regulatory submission.

Comments

Popular posts from this blog

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

AMBODE,SOYINKA & OTHERS AT THE OFFICIAL LAUNCH OF LAGOS AT 50 YEARS ANNIVERSARY AGAINST 2017.{PHOTOS}.